Visible-Light-Mediated [4+2] Cycloaddition of Styrenes: Synthesis of Tetralin Derivatives
作者:Leifeng Wang、Fengjin Wu、Jiean Chen、David A. Nicewicz、Yong Huang
DOI:10.1002/anie.201702940
日期:2017.6.6
We report a formal [4+2] cycloaddition reaction of styrenes under visible‐light catalysis. Two styrene molecules with different electronic or steric properties were found to react with each other in good yield and excellent chemo‐ and regioselectivity. This reaction provides direct access to polysubstituted tetralin scaffolds from readily available styrenes. Sophisticated tricyclic and tetracyclic
5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE
申请人:WARNER-LAMBERT COMPANY
公开号:EP1276725A2
公开(公告)日:2003-01-22
US6943183B2
申请人:——
公开号:US6943183B2
公开(公告)日:2005-09-13
[EN] 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE<br/>[FR] TETRALONES 5-SUBSTITUEES EN TANT QU'INHIBITEURS DE RAS FARNESYL TRANSFERASE
申请人:WARNER LAMBERT CO
公开号:WO2001079180A2
公开(公告)日:2001-10-25
The present invention provides novel 5-substituted tetralones of Formulas (I), (II), (III) and (IV) and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme.